Insider · CIK 0001610732

Greene John

Reports to the SEC for 5 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001610732

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-05	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2026-02-11	NOCNORTHROP GRUMMAN CORP /DE/ · Restricted Performance Stock RightsA Award	CVP & Chief Financial Officer	AAward	+4,981 sh	—	—	4,981
2026-02-11	NOCNORTHROP GRUMMAN CORP /DE/ · Restricted Stock RightsA Award	CVP & Chief Financial Officer	AAward	+5,362 sh	—	—	5,362
2025-06-05	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2025-05-18	Discover Financial ServicesD Disposition to Issuer	EVP, Chief Financial Officer	DDisposition to Issuer	−79.9K sh	—	—	0
2025-02-26	CRSPCRISPR Therapeutics AGP Purchase	Director	PPurchase	+7,000 sh	$44.85	+$314K	7,000
2025-02-01	Discover Financial ServicesF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−1,840 sh	$201.09	−$370K	79,866
2025-01-23	Discover Financial ServicesA Award	EVP, Chief Financial Officer	AAward	+14.6K sh	—	—	81,706
2024-12-19	Discover Financial ServicesA Award	EVP, Chief Financial Officer	AAward	+12.1K sh	—	—	78,778
2024-12-19	Discover Financial ServicesF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−11.7K sh	$169.27	−$1.98M	67,076
2024-05-30	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2024-02-22	Discover Financial ServicesA Award	EVP, Chief Financial Officer	AAward	+29.3K sh	—	—	57,427
2024-02-22	Discover Financial ServicesA Award	EVP, Chief Financial Officer	AAward	+9,051 sh	—	—	66,478
2024-02-01	Discover Financial ServicesA Award	EVP, Chief Financial Officer	AAward	+21.8K sh	—	—	40,393
2024-02-01	Discover Financial ServicesA Award	EVP, Chief Financial Officer	AAward	+21.8K sh	—	—	40,393
2024-02-01	Discover Financial ServicesF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−12.3K sh	$106.56	−$1.31M	28,103
2024-02-01	Discover Financial ServicesF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−12.3K sh	$106.56	−$1.31M	28,103
2024-01-26	Discover Financial ServicesS Sale	EVP, Chief Financial Officer	SSale	−35.2K sh	$106.51	−$3.75M	18,592
2023-06-08	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2023-02-23	Discover Financial ServicesA Award	EVP, Chief Financial Officer	AAward	+9,960 sh	—	—	53,539
2023-02-01	Discover Financial ServicesA Award	EVP, Chief Financial Officer	AAward	+25.2K sh	—	—	57,662
2023-02-01	Discover Financial ServicesF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−14.1K sh	$115.83	−$1.63M	43,579
2022-08-01	Discover Financial ServicesF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−1,752 sh	$102.22	−$179K	32,275.457
2022-06-09	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2022-02-25	Discover Financial ServicesA Award	EVP, Chief Financial Officer	AAward	+7,339 sh	—	—	33,952
2022-02-15	Discover Financial ServicesS Sale	EVP, Chief Financial Officer	SSale	−4,443 sh	$127.95	−$568K	26,613
2022-02-01	Discover Financial ServicesF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−2,079 sh	$118.02	−$245K	31,056
2021-08-01	Discover Financial ServicesF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−1,752 sh	$124.32	−$218K	33,135
2021-06-10	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-02-19	Discover Financial ServicesA Award	EVP, Chief Financial Officer	AAward	−9,690 sh	—	—	34,887
2021-02-01	Discover Financial ServicesF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−1,146 sh	$82.19	−$94.2K	25,197
2020-08-01	Discover Financial ServicesF Tax Payment	EVP, Chief Financial Officer	FTax Payment	−1,159 sh	$49.43	−$57.3K	26,343
2020-06-11	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2020-01-27	Discover Financial ServicesP Purchase	EVP, Chief Financial Officer	PPurchase	+3,377 sh	$73.84	+$249K	27,502
2020-01-22	Discover Financial ServicesA Award	EVP, Chief Financial Officer	AAward	+11.2K sh	—	—	24,125
2019-09-18	Discover Financial ServicesA Award	EVP, Chief Financial Officer	AAward	+11.9K sh	—	—	12,927
2019-06-11	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2018-03-08	Bioverativ Inc.D Disposition to Issuer	EVP, CFO and Treasurer	DDisposition to Issuer	−5,951.011 sh	—	—	0
2018-03-08	Bioverativ Inc.Restricted Stock UnitsD Disposition to Issuer	EVP, CFO and Treasurer	DDisposition to Issuer	−14.2K sh	—	—	0
2018-03-08	Bioverativ Inc.Restricted Stock UnitsD Disposition to Issuer	EVP, CFO and Treasurer	DDisposition to Issuer	−42.7K sh	—	—	0
2018-03-08	Bioverativ Inc.Non-Qualified Stock OptionD Disposition to Issuer	EVP, CFO and Treasurer	DDisposition to Issuer	−113K sh	—	—	0
2018-03-08	Bioverativ Inc.Non-Qualified Stock OptionD Disposition to Issuer	EVP, CFO and Treasurer	DDisposition to Issuer	−56.6K sh	—	—	0
2018-02-14	Bioverativ Inc.M Exercise/Conversion	EVP, CFO and Treasurer	MExercise/Conversion	+7,114 sh	—	—	7,614.057
2018-02-14	Bioverativ Inc.F Tax Payment	EVP, CFO and Treasurer	FTax Payment	−2,118 sh	$103.52	−$219K	5,496.057
2018-02-14	Bioverativ Inc.Restricted Stock UnitsM Exercise/Conversion	EVP, CFO and Treasurer	MExercise/Conversion	−7,114 sh	—	—	14,230
2018-01-31	Bioverativ Inc.Restricted Stock UnitsA Award	EVP, CFO and Treasurer	AAward	+42.7K sh	—	—	42,727
2017-02-14	Bioverativ Inc.Non-Qualified Stock OptionA Award	EVP, CFO and Treasurer	AAward	+56.6K sh	—	—	56,615
2017-02-14	Bioverativ Inc.Non-Qualified Stock OptionA Award	EVP, CFO and Treasurer	AAward	+113K sh	—	—	113,230
2017-02-14	Bioverativ Inc.Non-Qualified Stock OptionA Award	EVP, CFO and Treasurer	AAward	+56.5K sh	—	—	56,514
2017-02-14	Bioverativ Inc.Non-Qualified Stock OptionA Award	EVP, CFO and Treasurer	AAward	+113K sh	—	—	113,028

Recent filings

Accepted (ET)
Jun 94
Greene John0001193125-26-264288
SEC(opens sec.gov)
Feb 134
Greene John0001628280-26-008122
SEC(opens sec.gov)
Jun 64
Greene John0000950170-25-083270
SEC(opens sec.gov)
May 194
Greene John0000950170-25-074571
SEC(opens sec.gov)
Feb 284
Greene John0000950170-25-030181
SEC(opens sec.gov)
Feb 44
Greene John0000950170-25-013589
SEC(opens sec.gov)
Jan 274
Greene John0000950170-25-009357
SEC(opens sec.gov)
Dec 234
Greene John0000950170-24-139707
SEC(opens sec.gov)
May 314
Greene John0000950170-24-067324
SEC(opens sec.gov)
Feb 264
Greene John0000950170-24-020305
SEC(opens sec.gov)
Feb 54
Greene John0001209191-24-002874
SEC(opens sec.gov)
Feb 54
Greene John0001209191-24-002867
SEC(opens sec.gov)
Jan 304
Greene John0001209191-24-002412
SEC(opens sec.gov)
Jun 94
Greene John0001209191-23-035977
SEC(opens sec.gov)
Feb 274
Greene John0001209191-23-013158
SEC(opens sec.gov)

Companies

Address

C/O CRISPR THERAPEUTICS 105 WEST FIRST STREET

BOSTON, MA, 02127